Arcadia Investment Advisors’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-22
| Closed | -$55 | – | 88 |
|
2022
Q4 | $55 | Hold |
22
| – | – | ﹤0.01% | 89 |
|
2022
Q3 | $51 | Hold |
22
| – | – | ﹤0.01% | 89 |
|
2022
Q2 | $69 | Hold |
22
| – | – | ﹤0.01% | 112 |
|
2022
Q1 | $81 | Hold |
22
| – | – | ﹤0.01% | 112 |
|
2021
Q4 | $86 | Hold |
22
| – | – | ﹤0.01% | 112 |
|
2021
Q3 | $140 | Hold |
22
| – | – | ﹤0.01% | 113 |
|
2021
Q2 | $177 | Hold |
22
| – | – | ﹤0.01% | 241 |
|
2021
Q1 | $242 | Hold |
22
| – | – | ﹤0.01% | 100 |
|
2020
Q4 | $100 | Hold |
22
| – | – | ﹤0.01% | 111 |
|
2020
Q3 | $129 | Hold |
22
| – | – | ﹤0.01% | 105 |
|
2020
Q2 | $123 | Hold |
22
| – | – | ﹤0.01% | 75 |
|
2020
Q1 | $118 | Hold |
22
| – | – | ﹤0.01% | 77 |
|
2019
Q4 | $139 | Hold |
22
| – | – | ﹤0.01% | 61 |
|
2019
Q3 | $71 | Hold |
22
| – | – | ﹤0.01% | 69 |
|
2019
Q2 | $91 | Hold |
22
| – | – | ﹤0.01% | 67 |
|
2019
Q1 | $81 | Hold |
22
| – | – | ﹤0.01% | 64 |
|
2018
Q4 | $67 | Hold |
22
| – | – | ﹤0.01% | 65 |
|
2018
Q3 | $115 | Hold |
22
| – | – | ﹤0.01% | 58 |
|
2018
Q2 | $100 | Hold |
22
| – | – | ﹤0.01% | 69 |
|
2018
Q1 | $93 | Hold |
22
| – | – | ﹤0.01% | 59 |
|
2017
Q4 | $89 | Buy |
+22
| New | +$89 | ﹤0.01% | 66 |
|